Skip to main content
. 2021 Jul 8;16:1303–1313. doi: 10.2147/CIA.S312129

Table 2.

Comparisons of Basic and Clinical Features of Training and Validation Set According to Atherosclerosis

Training Set (n =1022) Validation Set (n = 430)
No AS (n = 541) AS (n = 481) P-value No AS (n = 242) AS (n = 188) P-value
Age, n (%) 48.6±13.1 62.0±11.7 <0.001 46.6±13.3 61.9±12.3 <0.001
Male, n (%) 286(52.9%) 342(71.1%) <0.001 126(52.1%) 120(63.8%) 0.014
CKD stage, n (%)
 Stage 1–2 84(15.5%) 46(9.6%) 0.029 28(11.6%) 13(6.9%) 0.237
 Stage 3 90(16.6%) 93(19.3%) 40(16.5%) 38(20.2%)
 Stage 4 94(17.4%) 80(16.6%) 36(14.9%) 35(18.6%)
 Stage 5 273(50.5%) 262(54.5%) 138(57.0%) 102(54.3%)
Cardiovascular disease, n(%) 143(26.4%) 210(43.7%) <0.001 62(25.6%) 84(44.7%) <0.001
Diabetes, n (%) 85(15.7%) 172(35.8%) <0.001 36(14.9%) 87(46.3%) <0.001
Hypertension, n (%) 381(70.4%) 388(80.7%) <0.001 172(71.1%) 161(85.6%) <0.001
Smoking, n (%) 142(26.2%) 185(38.5%) <0.001 59(24.4%) 61(32.4%) 0.064
Drinking, n (%) 119(22.0%) 139(28.9%) 0.011 54(22.3%) 54(28.7%) 0.128
Body mass index, kg/m2 23.3±3.7 23.9±3.6 0.013 23.3±3.7 23.7±3.7 0.291
Systolic blood pressure, mmHg 140.8±24.0 143.3±25.8 0.098 140.6±24.9 144.0±24.2 0.163
Uric acid, μmol/L 426.6±130.3 426.3±131.8 0.975 434.2±135.1 419.2±124.7 0.241
Serum hemoglobin, g/L 102.4±26.8 100.2±25.8 0.202 99.9±25.6 101.3±27.0 0.607
Albumin, g/L 38.7(33.2–42.8) 36.0(30.8–40.3) <0.001 38.5(33.1–41.9) 37.8(34.1–41.6) 0.718
Phosphorus, mmol/L 1.44±0.48 1.40±0.50 0.144 1.48±0.51 1.43±0.51 0.272
Calcium, mmol/L 2.20(2.05–2.30) 2.14(2.02–2.28) 0.018 2.20(2.06–2.32) 2.18(2.07–2.29) 0.486
Intact parathyroid hormone, pg/mL 161.5(62.2–363.4) 187.8(73.6–361.5) 0.336 163.2(82.6–360.8) 166.0(79.5–341.2) 0.986
Platelet counts, 109/L 182.5(129.3–234.0) 173.0(128.0–227.0) 0.185 184.0(137.5–241.5) 168.0(122.0–218.0) 0.014
Blood glucose, mmol/L 4.59(4.20–5.15) 4.75(4.18–5.96) 0.005 4.56(4.19–5.23) 5.08(4.41–6.38) <0.001
Urine total protein, g/24h 1.86(0.63–3.52) 2.12(0.70–4.62) 0.034 1.73(0.61–4.23) 1.90(0.78–3.83) 0.632
C-reactive protein, mg/L 4.10(2.20–8.40) 5.00(2.50–15.00) <0.001 4.50(2.30–12.30) 5.10(2.60–17.25) 0.108
Total cholesterol, mmol/L 4.38(3.56–5.23) 4.32(3.63–5.32) 0.919 4.21(3.52–5.15) 4.19(3.54–5.17) 0.978
Triglyceride, mmol/L 1.53(1.08–2.23) 1.48(1.09–2.11) 0.494 1.47(1.06–2.12) 1.56(1.11–2.08) 0.651
High density lipoprotein, mmol/L 1.04(0.87–1.29) 1.05(0.84–1.25) 0.356 1.03(0.84–1.31) 1.04(0.88–1.29) 0.905
Low density lipoprotein, mmol/L 2.29(1.82–2.98) 2.38(1.81–3.01) 0.453 2.34(1.86–2.95) 2.31(1.71–3.13) 0.786

Notes: Uric acid: mg/dL=μmol/L×0.01681, Serum hemoglobin, g/dL=g/L×0.1, Albumin: g/dL=g/L×0.1, Phosphorus: mg/dL=mmol/L×3.097, Calcium: mg/dL=mmol/L×4.008, Intact parathyroid hormone: mg/dL=pg/mL, Platelet counts: mm3=109/L×1000, Blood glucose: mg/dL =mmol/L×18.02, C-reactive protein: mg/dL=mg/L×0.1, Total cholesterol: mg/dL=mmol/L×38.67, Triglyceride: mg/dL=mmol/L×88.545, High density lipoprotein: mg/dL=mmol/L×38.61, Low density lipoprotein: mmol/L mg/dL=mmol/L×38.61.

Abbreviations: CKD, chronic kidney disease; AS, atherosclerosis.